Dr. Christopher Lavergne, MD
What this data tells you about Dr. Lavergne
Dr. Christopher Lavergne is a cardiovascular disease specialist in The Woodlands, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lavergne performed 5,898 Medicare services across 3,741 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lavergne received a total of $117,646 from 25 pharmaceutical and/or device companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lavergne is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
942 | $86 | $210 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
847 | $10 | $90 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
762 | $42 | $125 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
396 | $6 | $50 |
| Chemical injection for multiple incompetent leg veins A procedure involving the injection of a chemical agent into several non-functioning veins in the leg. |
246 | $144 | $500 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
236 | $89 | $400 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
213 | $141 | $1,300 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
205 | $55 | $395 |
| Intraoperative ultrasound guidance Use of ultrasound imaging during a surgical procedure to help guide the surgeon's actions. |
204 | $141 | $500 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
199 | $1,073 | $3,750 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 199 | $626 | $798 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
190 | $826 | $5,500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
141 | $62 | $140 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
120 | $92 | $190 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
104 | $133 | $600 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
95 | $15 | $125 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
94 | $19 | $125 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
94 | $17 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $116 | $310 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
87 | $27 | $145 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
61 | $20 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
56 | $134 | $400 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
49 | $56 | $225 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
40 | $1,290 | $6,000 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
38 | $138 | $650 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $76 | $210 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
26 | $126 | $333 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
25 | $20 | $83 |
| Ultrasound-guided injection into multiple incompetent leg veins A procedure where a chemical agent is injected into several faulty veins in the same leg. Ultrasound guidance is used to ensure accurate placement of the injection. |
22 | $1,094 | $4,290 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
19 | $6 | $63 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
19 | $2 | $120 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $116 | $375 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
16 | $84 | $571 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
15 | $83 | $350 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for cardiovascular disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lavergne is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 11% in TX), with speaking/promotional industry engagement in the top 5% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lavergne experienced with office visit, established patient (30-39 min)?
Does Dr. Lavergne receive payments from pharmaceutical companies?
How do Dr. Lavergne's costs compare to other cardiologists in The Woodlands?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology